Patents by Inventor Andrew Sylvester

Andrew Sylvester has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHOSPHATE RESISTANT ELECTRODEPOSITABLE COATING COMPOSITIONS
    Publication number: 20240076520
    Abstract: The present invention is directed to an electrodepositable coating composition comprising an electrodepositable binder comprising an ionic salt group-containing film-forming polymer comprising active hydrogen functional groups, and a blocked polyisocyanate curing agent; a solubilized bismuth catalyst; and a guanidine; wherein the electrodepositable coating composition has a weight ratio of bismuth metal from the solubilized bismuth catalyst to guanidine of from 1.00:0.071 to 1.0:2.1 and/or a molar ratio of bismuth metal to guanidine of from 1.0:0.25 to 1.0:3.0. Also disclosed are methods of treating electrodepositable coating compositions, methods for making electrodepositable coating compositions, systems for coating a metal substrate, coatings, coated substrates, and methods of coating a substrate.
    Type: Application
    Filed: December 30, 2021
    Publication date: March 7, 2024
    Applicant: PPG Industries Ohio, Inc.
    Inventors: Elizabeth Stephenie Brown-Tseng, Lee Brent Steely, Richard F. Syput, Corey James Dedomenic, Christopher Andrew Dacko, Egle Puodziukynaite, Kevin Thomas Sylvester, Benjamin Kabagambe, Katie Marie Cumpston, David Alfred Stone
  • Multiple-bore solute cartridge carrier
    Patent number: 11097965
    Abstract: A multiple-bore solute cartridge carrier 10) for use in a sterile fluid delivery system. The carrier includes a rotary housing (12) adapted for connection to the sterile fluid delivery system. The rotary housing has one or more bores (30) configured to receive a solute cartridge. The rotary housing, when connected to the sterile fluid delivery system, is selectively rotatable to facilitate creation of a desired sterile solution when sterile water from the fluid delivery system is flowed through the solute cartridge.
    Type: Grant
    Filed: March 14, 2016
    Date of Patent: August 24, 2021
    Assignees: THE CLEVELAND CLINIC FOUNDATION, PARKER-HANNIFIN CORPORATION
    Inventors: Joseph Foss, Paul Resendes, Gino Banco, Andrew Sylvester
  • MULTIPLE-BORE SOLUTE CARTRIDGE CARRIER
    Publication number: 20180044208
    Abstract: A multiple-bore solute cartridge carrier 10) for use in a sterile fluid delivery system. The carrier includes a rotary housing (12) adapted for connection to the sterile fluid delivery system. The rotary housing has one or more bores (30) configured to receive a solute cartridge. The rotary housing, when connected to the sterile fluid delivery system, is selectively rotatable to facilitate creation of a desired sterile solution when sterile water from the fluid delivery system is flowed through the solute cartridge.
    Type: Application
    Filed: March 14, 2016
    Publication date: February 15, 2018
    Inventors: Joseph Foss, Paul Resendes, Gino Banco, Andrew Sylvester
  • NANOPARTICLES FOR CONTROLLED LYSIS OF BLOOD CLOTS
    Publication number: 20170296480
    Abstract: Fibrinolytic nanoparticles including a polymeric core having a surface that is functionalized with a cationic amphiphilic compound, and a fibrinolytic agent dispersed within the core, are described herein. The fibrinolytic nanoparticles can be used in method of dissolving a blood clot in a subject by administering to the subject a therapeutically effective amount of fibrinolytic nanoparticles.
    Type: Application
    Filed: May 11, 2017
    Publication date: October 19, 2017
    Inventors: Anand Ramamurthi, Balakrishnan Sivaraman, Andrew Sylvester
  • Nanoparticles for controlled lysis of blood clots
    Patent number: 9675560
    Abstract: Fibrinolytic nanoparticles including a polymeric core having a surface that is functionalized with a cationic amphiphilic compound, and a fibrinolytic agent dispersed within the core, are described herein. The fibrinolytic nanoparticles can be used in method of dissolving a blood clot in a subject by administering to the subject a therapeutically effective amount of fibrinolytic nanoparticles.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: June 13, 2017
    Assignee: The Cleveland Clinic Foundation
    Inventors: Anand Ramamurthi, Balakrishnan Sivaraman, Andrew Sylvester
  • NANOPARTICLES FOR CONTROLLED LYSIS OF BLOOD CLOTS
    Publication number: 20150064267
    Abstract: Fibrinolytic nanoparticles including a polymeric core having a surface that is functionalized with a cationic amphiphilic compound, and a fibrinolytic agent dispersed within the core, are described herein. The fibrinolytic nanoparticles can be used in method of dissolving a blood clot in a subject by administering to the subject a therapeutically effective amount of fibrinolytic nanoparticles.
    Type: Application
    Filed: August 28, 2014
    Publication date: March 5, 2015
    Inventors: Anand Ramamurthi, Balakrishnan Sivaraman, Andrew Sylvester